Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2000
10/05/2000WO2000058463A1 Polynucleotide and deduced amino acid sequences from stromal cells
10/05/2000WO2000058361A1 Melanocortin receptor ligands
10/05/2000WO2000058355A1 50 human secreted proteins
10/05/2000WO2000058350A1 49 human secreted proteins
10/05/2000WO2000058339A2 50 human secreted proteins
10/05/2000WO2000058337A1 Liver specific bile acid derivatives of the glucocorticoid antagonist ru486
10/05/2000WO2000058334A1 50 human secreted proteins
10/05/2000WO2000058307A2 Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands
10/05/2000WO2000058305A1 Novel compounds
10/05/2000WO2000058304A1 Heterocyclic sulfonamide derivatives
10/05/2000WO2000058296A1 Protease inhibitors
10/05/2000WO2000058295A2 Compounds and methods for treatment of asthma, allergy and inflammatory disorders
10/05/2000WO2000058292A1 Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives
10/05/2000WO2000058280A1 Carbocyclic sulfonamide derivatives
10/05/2000WO2000057920A2 Method for expressing proteins
10/05/2000WO2000057916A1 Sphingomyelin containing preparation for the enhancement of tumor therapy
10/05/2000WO2000057903A2 48 human secreted proteins
10/05/2000WO2000057901A1 Modulation of vascular permeability by means of tie2 receptor activators
10/05/2000WO2000057897A1 Use of a lectin or conjugates for modulation of c-fibre activity
10/05/2000WO2000057884A1 Medicinal preparation containing at least in part acetylsalicylic acid as active ingredient
10/05/2000WO2000057877A1 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof
10/05/2000WO2000057862A2 Use of gaba-b receptor ligands for the treatment of neurodegenerative diseases
10/05/2000WO2000057727A1 Nutritional compositions which contain slightly negatively charged, non-digestible polysaccharides and the use thereof for reducing transport through tight junctions
10/05/2000WO2000040217B1 Topical composition comprising n-acetylaldosamines or n-acetylamino acids
10/05/2000WO2000031280A3 Use of plus-strand synthesis elements in retroviral vectors
10/05/2000WO2000029574A3 Inflammation-associated genes
10/05/2000WO2000028039A3 Identification of senv genotypes
10/05/2000WO2000026243A3 Transmembrane 4 proteins
10/05/2000WO2000025602A3 Use of calcareous material for foodstuff and cosmetic material
10/05/2000WO2000005249A3 Synthetic peptides and methods of use for autoimmune disease therapies
10/05/2000WO1999053951A9 Terminally-branched polymeric linkers and polymeric conjugates containing the same
10/05/2000WO1998041232A3 Compositions for modulating responsiveness to corticosteroids
10/05/2000CA2707691A1 Sphingomyelin containing preparation
10/05/2000CA2383592A1 2384891 acids including open reading frames encoding polypeptides; orfx
10/05/2000CA2369458A1 47 human secreted proteins
10/05/2000CA2368951A1 50 human secreted proteins
10/05/2000CA2368927A1 45 human secreted proteins
10/05/2000CA2368881A1 50 human secreted proteins
10/05/2000CA2368719A1 50 human secreted proteins
10/05/2000CA2368700A1 49 human secreted proteins
10/05/2000CA2368641A1 Use of a lectin or conjugates for modulation of c-fibre activity
10/05/2000CA2368631A1 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof
10/05/2000CA2368477A1 Polynucleotide and deduced amino acid sequences from stromal cells
10/05/2000CA2368467A1 50 human secreted proteins
10/05/2000CA2368442A1 48 human secreted proteins
10/05/2000CA2368302A1 49 human secreted proteins
10/05/2000CA2368281A1 50 human secreted proteins
10/05/2000CA2368090A1 Compounds and methods for treatment of asthma, allergy and inflammatory disorders
10/05/2000CA2367792A1 Liver specific bile acid derivatives of the glucocorticoid antagonist ru486
10/05/2000CA2366305A1 Method for expressing proteins
10/05/2000CA2365401A1 Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands
10/05/2000CA2361366A1 Novel compounds
10/04/2000EP1041072A1 Dioxocyclopentyl hydroxamic acids
10/04/2000EP1040838A1 Stable aqueous EM 12 solution
10/04/2000EP1040196A2 Transgenic animal model for degenerative diseases of cartilage
10/04/2000EP1040194A1 Human signal transduction serine/threonine kinase
10/04/2000EP1040191A2 Rantes mutants and therapeutic applications thereof
10/04/2000EP1040190A1 Serine proteinase inhibitors
10/04/2000EP1040118A1 Secreted proteins and polynucleotides encoding them
10/04/2000EP1040117A1 110 human secreted proteins
10/04/2000EP1040112A1 Imidazonaphthyridines and their use in inducing cytokine biosynthesis
10/04/2000EP1040111A1 Integrin receptor antagonists
10/04/2000EP1040100A1 Therapeutically active compounds based on indazole bioisostere replacement of catechol in pde4 inhibitors
10/04/2000EP1040099A1 Azepine or larger medium ring derivatives and their use as pharmaceuticals
10/04/2000EP1040098A1 Integrin receptor antagonists
10/04/2000EP1039911A1 MORPHOLINO-N-ETHYL ESTER PRODRUGS OF INDOLE sPLA 2 INHIBITORS
10/04/2000EP1039893A1 Pharmaceutical compositions containing an omega-3 fatty acid oil
10/04/2000EP1019040A4 INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS
10/04/2000EP0772610B1 Dihydrobenzofuranes
10/04/2000EP0766672B1 Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors
10/04/2000CN1269013A Moleculars withch give out multiple active parts
10/04/2000CN1268373A Hanshigutonging medicine for curing arthralgia caused by cold-dampness
10/04/2000CN1268360A Medicated liquor for curing rheumatism
10/04/2000CN1057097C Chimeric proteins which block complement activation
10/04/2000CN1057013C Novel 1 L-2 receptor-specific human immunoglobins
10/04/2000CN1057001C Traditional Chinese medicine capsule for treating rheumatoid disease
10/03/2000US6127554 2,4-bis[(4-amidino)phenyl]furans as anti-Pneumocystis carinii agents
10/03/2000US6127542 Chemical intermediates to specified pyrazino(2',1':6,1)pyrido(3,4b)indole-1,4-diones which are selective inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase; to treat cardiovascular disorders
10/03/2000US6127519 Calcitonin derivatives
10/03/2000US6127427 Active hydroxamic acids involved in tissue degradtion and also are inhibitors of the release of tumour necrosis factor from cells; rheumatoid arthritis, osteoarthritis, osteopenias such as osteoporosis, periodontitis, vision defects
10/03/2000US6127426 Antiallergic and -inflammatory agents e.g., treating psoriasis, blocked on the c-10 by a nonphenolic arylacyl or a phenylalkylidene group; lipoxygenase inhibitors; antiproliferative agents; low dosage; side effect reduction
10/03/2000US6127408 Thioether furan nitrone compounds; nervous system degenerative disorders, e.g. alzheimer's disease; analysis of free radicals by forming adducts; inhibit the forming of a beta(1-42) beta-pleated sheets and/or suppressing cytokines
10/03/2000US6127402 5-aroylpyrrol-2-ylmethylarene derivatives
10/03/2000US6127401 Treatment of prostate disorders, angiogenic disorders, neoplasia, rheumatoid arthritis, pulmonary fibrosis, myelofibrosis, abnormal wound healing, atherosclerosis, or restenosis, alzheimer's disease
10/03/2000US6127398 An enzyme inhibitor for the inhibition of phosphodiesterase typeiv or the production of tumor necrosis factor in a mammal; treating asthma, arthritis, bronchitis, chronic obstructive airway disease, psoriasis, allergic rhinitis
10/03/2000US6127387 Use of CD4-binding small molecules to inhibit immune responses
10/03/2000US6127382 An antiproliferative agent for treating skin-related diseases, an antitumor agent treating cancer, an antiinflammatory agent treating pulmonary fibrosis, ileitis, colitis and krohn's disease
10/03/2000US6127365 Tachykinin antagonists for treatment of pain, inflammation, migraine, emesis and postherpetic neuralgia.
10/03/2000US6126939 Anti-inflammatory dipeptide and pharmaceutical composition thereof
10/03/2000CA2000342C Novel peptidase inhibitors
09/2000
09/30/2000CA2302886A1 A stable aqueous solution of em 12
09/28/2000WO2000056910A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites
09/28/2000WO2000056891A2 Human transmembrane proteins
09/28/2000WO2000056889A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/28/2000WO2000056883A1 49 human secreted proteins
09/28/2000WO2000056882A1 48 human secreted proteins
09/28/2000WO2000056881A1 48 human secreted proteins
09/28/2000WO2000056862A1 Human tumor necrosis factor receptor tr9
09/28/2000WO2000056767A1 46 human secreted proteins
09/28/2000WO2000056766A1 47 human secreted proteins
1 ... 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 ... 1272